← Who reports today · Health Care
CVS earnings date & Q2 2026 results · CVS Health
US GAAP · $M · vs Q2 2025 · reported 08/05/2026
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. · Wikipedia
More about the company
The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.
Key growth driver: Health Services — the fastest-growing revenue line: $51,795, +12% y/y. · by the Q2 2026 report
When is CVS’s next earnings date?
Wednesday, November 4, 2026estimated
CVS Health (CVS) has not confirmed the date yet; Nov 4, 2026 is an estimate based on the company's past reporting schedule and may move once the date is announced. Consensus EPS forecast: $1.62 (9 analysts), vs $1.60 in the same quarter last year.
What time does CVS report? Usually before market open: the last 4 results releases reached the SEC at 6:32 am, 6:31 am, 6:31 am, 6:32 am ET.
Last report: Aug 5, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates and consensus: Nasdaq / Zacks Investment Research; companies do reschedule. Who else reports this week →
All figures in $M.
Revenue
$106,096
+7.3%
Gross profit
$47,234
Operating income
$4,703
+97.5%
4.4% margin
Net income
$2,995
+195.7%
$2.31 diluted EPS
Verdict: a strong quarter for CVS as revenue grew 7.3% on gains across all three segments and net income nearly tripled to $2,995M, driven mainly by the Health Care Benefits segment's margin recovery (MBR down to 87.4% from 89.9%) and the absence of last year's $833M legacy litigation charges, with only modest drag from continued elevated cost trends.
YTD operating cash flow $10,594M; dividends paid $1,725M YTD; FY2026 guidance raised to GAAP diluted EPS $6.84-$7.04, Adjusted EPS $7.90-$8.10, OCF at least $11.5B.
Source and notation
* marks non-cash / ≈ estimated. Source: CVS Health press release / 10-Q (SEC EDGAR).
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
CVS earnings history: past report dates
| Aug 5, 2026 Wed | 6:32 ambefore market open | Jun 30, 2026 | $106B+7% y/y | $2.31+189% y/y |
| May 6, 2026 Wed | 6:31 ambefore market open | Mar 31, 2026 | $100B+6% y/y | $2.30+63% y/y |
| Feb 10, 2026 Tue | 6:31 ambefore market open | Dec 31, 2025 | ≈$106B+8% y/y | ≈$2.31+78% y/y |
| Oct 29, 2025 Wed | 6:32 ambefore market open | Sep 30, 2025 | $103B+8% y/y | −$3.13 |
| Jul 31, 2025 Thu | 6:31 ambefore market open | Jun 30, 2025 | $98.9B+8% y/y | $0.80−43% y/y |
| May 1, 2025 Thu | 6:32 ambefore market open | Mar 31, 2025 | $94.6B+7% y/y | $1.41+60% y/y |
| Feb 12, 2025 Wed | 6:32 ambefore market open | Dec 31, 2024 | ≈$97.7B+4% y/y | ≈$1.30−18% y/y |
| Oct 18, 2024 Fri | 6:46 ambefore market open | Sep 30, 2024 | $95.4B+6% y/y | $0.07−96% y/y |
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
CVS Health: 5-year financials
| 2025 | 402,067 | 4,660 | 1,768 | 7,807 | 3,397 |
| 2024 | 372,809 | 8,516 | 4,614 | 6,326 | 3,373 |
| 2023 | 357,776 | 13,743 | 8,344 | 10,395 | 3,132 |
| 2022 | 322,467 | 7,954 | 4,311 | 13,450 | 2,907 |
| 2021 | 292,111 | 13,310 | 8,001 | 15,745 | 2,625 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP).
How we calculate
Figures are the annual report lines as filed, no adjustments. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing.
Corporate governance
2/2good
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
More
- Feb 20262025 10-K cover: a single class — Common Stock, $0.01 (NYSE: CVS). sec.gov ↗
- Feb 2026Diluted share count −3.3% over 2020–2025; SBC of $535M = 0.1% of $402B revenue (XBRL). data.sec.gov ↗
- Feb 2026Per-share dividend: $2.00 in 2017–2021, $2.20 in 2022, $2.42 in 2023, $2.66 in 2024–2025 — no cuts (XBRL). data.sec.gov ↗
- Feb 2026The 2019 class actions over the LTC business were dismissed by the courts (the last in Feb. 2025, under appeal); the 2024 suits over insurance-segment profitability are unresolved. sec.gov ↗
Scoring: 2.0 with no deductions = 2.0 (single share class, shares −3.3% over 5 years, dividend never cut, 2019 class actions dismissed by the court, 2024 suits unresolved)
- Share classes
- Single class of common stock (10-K cover: Common Stock, NYSE).
- Dilution
- Diluted shares −3.3% over 2020–2025, SBC 0.1% of revenue; buybacks of $8.5B over 2022–2024.
- Disclosure
- Full 10-K/10-Q reporting.
- Dividends
- $2.00 per share frozen in 2018–2021 (deleveraging after the Aetna acquisition), then $2.20 → $2.66; no cuts.
- Lawsuits & regulators
- 2019 suits (LTC/Omnicare): City of Miami — dismissed (affirmed by the 1st Circuit in 2022), City of Warren — dismissed 2023, Waterford — dismissed 2025 (on appeal); 2024 suits (Louisiana Sheriffs, SDNY) — at the motion stage, unresolved → no deduction. Opioid settlements are industry-wide, not a criterion.
- Related parties
- No material related-party transactions in the 2026 proxy.
How the score works · checked as of Sep 2026
CVS Health (CVS) earnings: FAQ
When is CVS's next earnings date?
CVS Health (CVS) has not confirmed the date yet; Nov 4, 2026 is an estimate based on its past reporting schedule.
What time does CVS report earnings?
CVS Health usually reports before market open: its latest results release was filed with the SEC at 6:32 am ET on Aug 5, 2026.
When did CVS last report earnings?
CVS Health reported Q2 2026 results on Aug 5, 2026.
What is the EPS estimate for CVS's next earnings?
The consensus EPS forecast is $1.62 (9 analysts), vs $1.60 in the same quarter last year.
Where can I find CVS Health's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CVS's filings; this page breaks the latest report down in a Sankey chart.
What was CVS's net income in Q2 2026?
CVS Health reported net income of $2,995M for Q2 2026 (+195.7% year over year), under US GAAP.
Does CVS Health pay dividends?
Yes. In 2025, CVS Health paid $3,397M in dividends on its common stock, per its 10-K. Earlier years are in the five-year table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report. Figures checked against the filing on 08/25/2026. How we make the breakdowns · Report an error
More reports: DHR · Q2 2026 · ELV · Q2 2026 · GILD · Q2 2026 · HCA · Q2 2026 · ISRG · Q2 2026 · JNJ · Q2 2026 · LLY · Q2 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · MRK · Q2 2026 · all reports